2581 - 2590 of 9034 Results
Title
Year
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 24End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 15
-
OPENTitle: Minimalist approaches to cancer tissue-of-origin classification by DNA methylationJournal Name: Modern PathologyPublisher: Elsevier BVVol: 33Issue #: 10Start Page: 1874End Page: 1888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41379-020-0547-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8808378Citation Count: 38
-
OPENTitle: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2022Issue #: 1Start Page: 5597503End Page: 5597503Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5597503Best OA location URL: https://downloads.hindawi.com/journals/pd/2022/5597503.pdfCitation Count: 5
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page: e376End Page: e389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 128
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 34
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
-
OPENTitle: Sea cucumber-derived extract can protect skin cells from oxidative DNA damage and mitochondrial degradation, and promote wound healingJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 180Issue #:Start Page: 117466End Page: 117466Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.biopha.2024.117466Best OA location URL: https://doi.org/10.1016/j.biopha.2024.117466Citation Count: 6
-
OPENTitle: Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndromeJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1872Issue #: 4Start Page: 168184End Page: 168184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbadis.2026.168184Best OA location URL: https://doi.org/10.1016/j.bbadis.2026.168184Citation Count: 0
-
OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 773999End Page: 773999Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 11
-
OPENTitle: Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System AtrophyJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 5Start Page: 906End Page: 906Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11050906Best OA location URL: https://www.mdpi.com/2073-4409/11/5/906/pdf?version=1646555264Citation Count: 41